[1] |
Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer[J]. Lancet, 2019, 393: 1240-1253.
|
[2] |
李家丽,刘颖. 非同源末端连接研究进展及其在肿瘤发生和治疗中的意义[J]. 基础医学与临床, 2019, 39: 899-903.
|
[3] |
Jiang H, Lin Y, Yang CQ, et al. Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk[J]. Tumour Biol, 2013, 34: 779-785.
|
[4] |
Li JJ, Gu QH, Li M, et al. Role of Ku70 and Bax in epigallocatechin-3-gallate-induced apoptosis of A549 cells in vivo[J]. Oncol Lett, 2013, 5: 101-106.
|
[5] |
张妍,鞠桂芝,张坪,等.Ku70在宫颈癌组织中的表达及意义[J]. 中国妇幼保健, 2009, 24:1700-1702.
|
[6] |
Rajaei M, Saadat I, Omidvari S, et al. Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer[J]. Med Oncol, 2014, 31: 1-4.
|
[7] |
Liu ZH, Wang N, Wang FQ, et al. High expression of XRCC5 is associated with metastasis through Wnt signal-ing pathway and predicts poor prognosis in patients with hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2019, 23: 7835-7847.
|
[8] |
Coleman RL, Spirtos NM, Enserro D, et al. Secondary surgical cytoreduction for recurrent ovarian cancer[J]. N Engl J Med, 2019, 381: 1929-1939.
|
[9] |
Hnizda A, Tesina P, Nguyen TB, et al. SAP domain forms a flexible part of DNA aperture in Ku70/80[J]. FEBS J, 2021, 288: 4382-4393.
|
[10] |
Geng F, Zhang Y, Lu Z, et al. Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70/p53 pathway in oral cancer cells[J]. DNA Cell Biol, 2020, 39: 144-151.
|
[11] |
Ihnen M, zu Eulenburg C, Kolarova T, et al. Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer[J]. Mol Cancer Ther, 2013, 12: 1002-1015.
|
[12] |
Pucci S, Mazzarelli P, Sesti F, et al. Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression[J]. Cell Cycle, 2009, 8: 473-481.
|